Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome
ObjectivesWe investigated the impact of secondary antiphospholipid syndrome (APS) and antiphospholipid antibody (aPL) positivity on the non-thromboembolic clinical manifestations of systemic lupus erythematosus (SLE).MethodsIn total, 224 patients with SLE were studied, of whom 105 were aPL-positive;...
Elmentve itt :
| Szerzők: |
Deák Magdolna Bocskai Márta Burcsár Szilárd Dányi O. Fekete Z. Kovács László |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2014
|
| Sorozat: | LUPUS
23 No. 9 |
| doi: | 10.1177/0961203314531839 |
| mtmt: | 2601977 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/9665 |
Hasonló tételek
-
Malignancies in systemic lupus erythematosus
Szerző: Kiss Emese, et al.
Megjelent: (2010) -
Profiles of criteria and non-criteria anti-phospholipid autoantibodies are associated with clinical phenotypes of the antiphospholipid syndrome
Szerző: Volkov Ilan, et al.
Megjelent: (2020) -
Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus
Szerző: Zhao Jian, et al.
Megjelent: (2015) -
Systemic lupus erythematosus with pigmented skin
Szerző: Török László, et al.
Megjelent: (1993) -
Characterization of the thrombin generation profile in systemic lupus erythematosus
Szerző: Kern Anita, et al.
Megjelent: (2017)